A research team from POSTECH has developed a biodegradable polymer-based delivery system that efficiently transports mRNA.

UCSF scientists discover how cancer cells hijack the protein factory of the cell to churn out MYC protein, the driver of 70% ...

TriLink BioTechnologies (TriLink®), a Maravai® LifeSciences company (NASDAQ: MRVI) and global provider of life science ...

A revolutionary personalized cancer vaccine developed by Russia’s Gamaleya Research Institute of Epidemiology and ...

The Kowalinski group at EMBL Grenoble discovered notable differences between the nuclear cap-binding complex in trypanosomes and humans, a critical component in cellular RNA metabolism. Trypanosomes ...

In this review of RNA therapies, we paint an overview of what’s going on in a field that is addressing a number of diseases.

Legislation that would block hospitals from transfusing blood containing COVID-19 antibodies or “synthetic mRNA” could have significant repercussions for the state’s blood supply.

Trypanosomes are parasites that cause sleeping sickness, Chagas disease, and various animal diseases. Diagnosis and treatment remain complex and no effective vaccine has been developed. A better ...

Lauren Gray is a New York-based writer and editor with nearly a decade of experience covering health, wellness, ...

One of the two NASA astronauts stuck in space got a much-welcome change of scenery when she stepped out for her first spacewalk after seven months in orbit. Suni Williams and Butch Wilmore have ...

Nasdaq took a key step toward listing Canary Capital's spot ... a 19b-4 filing would be needed to start the approval process. Hours later, Nasdaq submitted that critical filing.